Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1225 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
This article has been cited by
1Predictive Factors of Acute Rejection in Low Immunologic Risk Kidney Transplant Recipients Receiving Basiliximab
M. Pereira,J. Guerra,M. Neves,J. Gonçalves,A. Santana,C. Nascimento,A.G. da Costa
Transplantation Proceedings.2016;48(7)2280
[DOI]
2Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience
Hong-Feng Huang,Jing-Yi Zhou,Wen-Qing Xie,Jian-Yong Wu,Hao Deng,Jiang-Hua Chen
International Urology and Nephrology.2016;48(8)1363
[DOI]
3Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis
Kun Wang,Xianlin Xu,Min Fan
Clinical and Experimental Nephrology.2018;22(3)684
[DOI]
  My Preferences